@article{c38db23afe4e4466aa7a8e246ea3ce42,
title = "Funding and DSMB Membership in the VICTAS Clinical Trial",
author = "Howard Bauchner and Fontanarosa, {Phil B.} and Golub, {Robert M.}",
note = "Funding Information: The National Institutes of Health (NIH; which was not a funder of the VICTAS trial) is the largest single funder of biomedical research in the world. Clinical research is generally supported by grants or contracts, and it is very unusual for the NIH to withhold or withdraw funds for a study if appropriate documented progress is being made and no ethical or other scientific issues have arisen. However, in the past few decades, patient advocacy groups and new foundations, often with the active engagement of the individual(s) who created the foundation, have begun to fund biomedical research. It is important for investigators, and the offices of sponsored programs at the investigators{\textquoteright} institutions, who are usually responsible for the contractual relationship between an investigator (or institution) and the funder, to be aware of the details governing and ensuring the ongoing support of a study.",
year = "2021",
month = feb,
day = "23",
doi = "10.1001/jama.2020.25952",
language = "English (US)",
volume = "325",
pages = "751--752",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "8",
}